Previous close | 39.85 |
Open | 39.91 |
Bid | 0.00 x 1400 |
Ask | 0.00 x 1200 |
Day's range | 39.72 - 40.61 |
52-week range | 37.35 - 80.58 |
Volume | |
Avg. volume | 6,565,730 |
Market cap | 20.849B |
Beta (5Y monthly) | 0.56 |
PE ratio (TTM) | N/A |
EPS (TTM) | -4.83 |
Earnings date | 27 Apr 2023 |
Forward dividend & yield | 1.16 (2.91%) |
Ex-dividend date | 23 Feb 2023 |
1y target est | 48.48 |
DEERFIELD, Ill., March 29, 2023--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2023 Annual Meeting) in a virtual format on Tuesday, May 2, 2023 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the meeting. Online access to the meeting will begin at 8:30 a.m., Central Time. Stockholders will not be able to attend the meeting in person. If you plan to attend the virtual meeting, please check https://investor.ba
After declining 19% in 2022, the S&P 500 has risen about 4% this year as investors grew accustomed to inflation, rising interest rates, and other macro headwinds. Let's see if the four worst-performing S&P 500 components so far in 2023 -- Lumen Technologies (NYSE: LUMN), Moderna (NASDAQ: MRNA), Baxter International (NYSE: BAX) and Pfizer (NYSE: PFE) -- are actually contrarian buys.
DEERFIELD, Ill., February 14, 2023--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on April 3, 2023, to shareholders of record as of February 24, 2023. The indicated annual dividend rate is $1.16 per share of common stock.